Rilonacept in Subjects with Cardiac Sarcoidosis
Status: Recruiting
Conditions: Myocarditis, Sarcoidosis
Location:
Johns Hopkins UniversityMayo Clinic in Rochester
City/State:
Baltimore, Maryland
Rochester, Minnesota
Contact Information:
Lezlie Peterson, R.N.
Phone Number: 507-255-2029
Email: [email protected]
Brief Summary: The primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial inflammation in subjects with cardiac sarcoidosis after 24 weeks of therapy.